Treatments & Interventions
Estrone
substance
Estrogen receptor agonist-containing product
product
Estradiol benzoate
substance
Estradiol valerate
substance
Estradiol cypionate
substance
Estradiol hemihydrate
substance
Polyestradiol phosphate
substance
Ethinylestradiol
substance
Conjugated estrogen
substance
Esterified estrogen
substance
Estradiol
substance
Sodium estrone sulfate
substance
Piperazine estrone sulfate
substance
Estradiol acetate
substance
Polyestradiol
substance
Estrogen receptor agonist
substance
Clinical Trials
Recent Trials
Identifying Genome Variants in Non-Obstructive Azoospermia (NOA) or Primary Ovarian Insufficiency (POI)
Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome
Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders
IMProving Executive Function Study
Evaluation of Physiologic and Standard Sex Steroid Replacement Regimens in Women With Premature Ovarian Failure
Research Evidence
Peer-reviewed studies linked via MeSH term "Ovarian Insufficiency, Primary" from the MEDLINE/PubMed database.
Research data from MEDLINE/PubMed
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Related Conditions
Quick Facts
- SNOMED CT
- 237788002
- UMLS CUI
- C0085215
- Fully Specified Name
- Premature ovarian failure (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 3
- Known Treatments
- 16
- Clinical Trials
- 7
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.